晨间信号Morning Signal
《新科学家》 第271卷 第3611期 · 2026年9月5日 · 中文解读

肌肉增强药物:GLP-1之后的下一个健康热点?

The next health hack · Michael Le Page
约 13 分钟Views已做好,小程序里马上能听2026-09-10 精选
这篇讲什么
本文探讨了正在临床试验中的肌肉增强药物,它们可能成为继GLP-1药物之后的下一个重大健康突破。
中文解读 · 试听前 3:00 / 全长 9:30
0:003:00
大壹讲,咪仔问。点字幕可跳到那一句。
试听到此为止。完整解读、逐句字幕和后台播放,在微信小程序「晨间信号」里听。
原文开头
Drugs designed to prevent muscle loss and boost muscle growth are being tested in clinical trials. Are these the next big thing after GLP-1 drugs, asks Michael Le Page BUILDING muscle is hard. Stop working out for just a few days and you start to lose it. What’s more, it gets tougher and tougher just to maintain muscle as we get older. But now a number of muscle-boosting drugs are being tested in clinical trials. Is staying strong into old age about to get much easier? The origin of this kind of muscle-boosting drug dates back to the 1990s, when a team in the US discovered a protein resembling known growth factors, which boost or hinder cell growth. …
摘自《新科学家》(New Scientist)第271卷 第3611期 · 2026年9月5日,Michael Le Page。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章